Exchange: NASDAQ·Updated 07:58 PM EDT
NYXH logo

NYXH Nyxoah SA

$1.62
$0.14
(7.96%)
Today
Closed $1.62
$0.0561
(3.46%)
After Hours
EarningsNov 5
Mkt Cap$164.98M
Vol1.01M

About NYXH

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.
72

Bullish Sentiment

How do you feel about NYXH?

Advertisement|Remove ads.